AMP receives FDA approval to manufacture ophthalmic product using Capmatic Patriot dropper bottle filling line

Alliance Medical Products ("AMP") announced today, at the AAPS Annual Meeting and Exposition, the U.S. Food and Drug Administration (FDA) has granted approval to manufacture a certain commercially available ophthalmic product using the company's high speed dropper bottle filling line.

“The FDA's approval to manufacture another commercial product in our facility further demonstrates AMP's ability to bring our customers' products successfully from clinical through commercial manufacture”

"The FDA's approval to manufacture another commercial product in our facility further demonstrates AMP's ability to bring our customers' products successfully from clinical through commercial manufacture," said Juan Valdes, President and CEO. "Over the years, we have enjoyed repeated success in transferring our customers' products to our 54,000 square foot facility in Irvine California and scaling those products up to full commercial manufacture."

The product is approved for immediate manufacture using AMP's high speed Capmatic Patriot dropper bottle filling line. The line is capable of filling 5,000 to 30,000 units per shift with container sizes ranging from 3mL to 30mL.

Steve Tulk, Vice President of Business Development and Kevin O'Brien, Director of Sales, will be available to discuss the company's capabilities during the exposition.

"We are very pleased to be participating in this premier industry conference," said Valdes. "We look forward to the opportunity to discuss our capabilities in person and further develop relationships with new and existing customers."